Phase I/II Study of Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone (BelCyd) in Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Badros, Ashraf Z. [1 ]
Nash, Thea [2 ]
Lawrance, Christopher [2 ]
Tittle, Brandon [2 ]
Philip, Sunita [3 ]
Sunshine, Sarah [4 ]
Munir, Wuqaas [4 ]
Fan, Xiaoxuan [5 ]
Ide, Christina [2 ]
Atanackovic, Djordje [3 ]
机构：
[1] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Greenebaum Canc Canter, Baltimore, MD 21201 USA
[3] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Flow Cytometry Shared Serv, Baltimore, MD 21201 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182254
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Belantamab mafodotin for relapsed or refractory multiple myeloma
    David Gil-Sierra, Manuel
    del Pilar Briceno-Casado, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1375 - 1380
  • [2] Belantamab mafodotin in the treatment of relapsed or refractory multiple myeloma
    Sheikh, Semira
    Lebel, Eyal
    Trudel, Suzanne
    FUTURE ONCOLOGY, 2020, 16 (34) : 2783 - 2798
  • [3] Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
    Condorelli, Annalisa
    Garibaldi, Bruno
    Gagliano, Caterina
    Romano, Alessandra
    Del Fabro, Vittorio
    Parrinello, Nunziatina Laura
    Longo, Antonio
    Cosentino, Sebastiano
    Di Raimondo, Francesco
    Conticello, Concetta
    ACTA HAEMATOLOGICA, 2024, 147 (04) : 493 - 498
  • [4] Belantamab-mafodotin treatment for relapsed or refractory multiple myeloma
    Stocker, Nicolas
    HEMATOLOGIE, 2020, 26 (02): : 99 - 100
  • [5] Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
    Condorelli, Annalisa
    Garibaldi, Bruno
    Gagliano, Caterina
    Romano, Alessandra
    Del Fabro, Vittorio
    Parrinello, Nunziatina Laura
    Longo, Antonio
    Cosentino, Sebastiano
    Di Raimondo, Francesco
    Conticello, Concetta
    ACTA HAEMATOLOGICA, 2021,
  • [6] The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
    Becnel, Melody R.
    Lee, Hans C.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [7] Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial
    Suzanne Trudel
    Arleigh McCurdy
    Martha L. Louzada
    Stephen Parkin
    Darrell White
    Michael P. Chu
    Rami Kotb
    Hira Mian
    Ibraheem Othman
    Jiandong Su
    Aniba Khan
    Engin Gul
    Donna Reece
    Nature Medicine, 2024, 30 : 543 - 551
  • [8] Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial
    Trudel, Suzanne
    Mccurdy, Arleigh
    Louzada, Martha L.
    Parkin, Stephen
    White, Darrell
    Chu, Michael P.
    Kotb, Rami
    Mian, Hira
    Othman, Ibraheem
    Su, Jiandong
    Khan, Aniba
    Gul, Engin
    Reece, Donna
    NATURE MEDICINE, 2024, 30 (02) : 543 - 551
  • [9] DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Rifkin, Robert
    Boyd, Kevin
    Grosicki, Sebastian
    Kim, Kihyun
    Di Raimondo, Francesco
    Dimopoulos, Meletios
    Weisel, Katja
    Arnulf, Bertrand
    Hajek, Roman
    Hungria, Vania
    Spencer, Andrew
    Davis, Randy
    Riccio, Antonio
    Kim, Chanbin
    Wilkes, Jodie
    Rutledge, Ruth
    Talekar, Mala
    Kremer, Brandon E.
    Gupta, Ira
    Mateos Manteca, Maria Victoria
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 172 - 173
  • [10] Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
    Dimopoulos, Meletios Athanasios
    Beksac, Meral
    Pour, Ludek
    Delimpasi, Sosana
    Vorobyev, Vladimir
    Quach, Hang
    Spicka, Ivan
    Radocha, Jakub
    Robak, Pawel
    Kim, Kihyun
    Cavo, Michele
    Suzuki, Kazuhito
    Morris, Kristin
    Pompilus, Farrah
    Phillips-Jones, Amy
    Zhou, Xiaoou L.
    Fulci, Giulia
    Sule, Neal
    Kremer, Brandon E.
    Opalinska, Joanna
    Mateos, Maria-Victoria
    Trudel, Suzanne
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (05): : 408 - 421
12345